Chemplast Sanmar (CHEMPLASTS) Q4 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 24/25 earnings summary
9 Jul, 2026Executive summary
FY25 consolidated revenue reached ₹4,346.07 crore, up 11% year-over-year, with EBITDA at ₹219 crore, a significant rise from ₹26 crore in FY24.
Net loss narrowed to ₹110.36 crore in FY25 from ₹158.43 crore in FY24, reflecting operational improvements despite persistent PVC industry headwinds.
Specialty chemicals and custom manufacturing drove growth, while PVC segments faced margin pressure due to global oversupply and dumping.
Audited standalone and consolidated financial results for FY25 were approved with an unmodified opinion; no dividend was declared.
Announced a greenfield capex of ₹340 crore for R32 refrigerant gas production, reinforcing growth in specialty chemicals.
Financial highlights
Q4 FY25 revenue was ₹1,151 crore, up 10% year-over-year; EBITDA for the quarter was ₹37 crore, up from ₹21 crore in Q4 FY24.
Specialty chemicals revenue for FY25 was ₹1,764 crore, up 53% year-over-year; value-added chemicals revenue rose 24% to ₹624 crore.
Suspension PVC revenue declined 6% year-over-year to ₹2,298 crore due to lower realizations and volumes.
Net cash from operating activities improved to ₹171.67 crore (consolidated) and ₹218.81 crore (standalone) in FY25.
Consolidated total comprehensive income for FY25 was ₹367.85 crore, reflecting significant revaluation gains.
Outlook and guidance
Specialty chemicals expected to drive future growth, with the R-32 refrigerant project (₹340 crore CapEx) targeted for completion by October 2025.
Guidance for custom manufacturing business remains at ₹1,000–1,100 crore revenue by FY27, with potential to surpass.
Anticipates improved pricing and demand environment in H2 FY26, especially if anti-dumping measures take effect.
Margins in Specialty Paste PVC and Suspension PVC expected to improve and sustain medium to long term due to global demand-supply tightness.
Custom Manufacturing revenue likely to grow with new facility commissioning and robust product pipeline.
Latest events from Chemplast Sanmar
- Record pre-exceptional PBT rose 7% as Cuddalore margins and lower costs lifted results.CHEMPLASTS
Q4 17/18 - Chloromethanes margins lifted FY19 PBT as a major scheme reshaped the business.CHEMPLASTS
Q4 18/19 - EBITDA margin rose to 30.7%; consolidated profit included major investment-redemption gains.CHEMPLASTS
Q4 20/21 - Higher depreciation, finance costs and COVID-19 pressure drove a sharp FY20 profit decline.CHEMPLASTS
Q4 19/20 - Record FY22 performance and IPO-led deleveraging fund the next capacity-growth phase.CHEMPLASTS
Q4 21/22 - Price and energy pressure cut FY23 earnings as major growth projects advanced.CHEMPLASTS
Q4 22/23 - Revenue rose 2% YoY but EBITDA turned negative amid high costs and market pressures.CHEMPLASTS
Q1 26/27 - Q1 FY25 saw strong revenue and profit growth, led by specialty chemicals and CMC expansion.CHEMPLASTS
Q1 24/25 - Q1 FY26 saw a 4% YoY revenue drop, net loss, and one-time tax and revaluation impacts.CHEMPLASTS
Q1 25/26